Dr.Max made a net profit of CZK 762 mil with revenues of CZK 24,796 mil in 2022, up by 31.7% and up by 9.88%, respectively, compared to the previous year. This translates into a net margin of 3.07%.
Historically, between 2013 - 2022, the firm’s net profit reached a high of CZK 828 mil in 2014 and a low of CZK -187 mil in 2015. Since 2017, the firm's net profit has increased 476% or 41.9% a year on average.
On the operating level, EBITDA reached CZK 1,702 mil, up 15.9% compared to the previous year. Over the last five years, company's EBITDA has risen 13.8% a year on average.
You can see all the company’s data at Dr.Max profile, or you can download a report on the company in the report section.
Helgi Library 
